Telomir Pharmaceuticals reports preclinical cancer findings
Go back to Telomir Pharmaceuticals reports preclinical cancer findings| (NASDAQ: TELO) | Delayed: 1.22 +0.01 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $ | |||
| Open | $1.22 | 52 Week Low | $ | |||
| Day High | $1.23 | P/E | N/A | |||
| Day Low | $1.20 | EPS | $ | |||
| Volume | 36,270 | |||||
